Global investment firm Index Ventures announced the establishment of JinYi connect (Singapore) Fund in Singapore. This strategic move marks a significant leap forward for Index Ventures and JinYi conn
The biopharmaceutical field has recently witnessed several disruptive breakthroughs, with innovative achievements, particularly those represented by technologies independently developed in China, attr
As large-scale artificial intelligence models move from laboratories to factory workshops, as humanoid robots perform precise movements in the torch relay, and as drone logistics routes weave a networ
When gene editing technology achieves the leap of "one treatment for multiple diseases," when artificial intelligence compresses the new drug development cycle from ten years to a few months, and when
In 2025, the global technology startup industry is at a critical juncture of "deepening cross-border integration and accelerated technology implementation." From the national-level strategic deploymen
The global biopharmaceutical industry in 2025 is witnessing a paradoxical and fascinating "tale of ice and fire." On the one hand, the lingering effects of the capital winter remain, with the financin
As a technology company deeply rooted in the field of smart living, JinYu firmly believes that "technology should be people-oriented." The newly launched JinYu App is not only a deep implementation of
According to authoritative sources, the digital service project jointly developed by Kinglink and the Hong Kong government has been officially implemented, and Kinglink's JinYu APP has also been offic
In Hong Kong, a super-aged society where one in four people is over 65, 78-year-old Grandma Chan, like countless others her age, was troubled by the application process for the Old Age Living Allowanc
Xiyuan Anjian Pharmaceutical (Beijing) Co., Ltd. (hereinafter referred to as "Xiyuan Anjian"), a drug R&D company focusing on developing innovative therapeutic drugs in the field of pain management, r
As a strategic foothold for Index Ventures' Asia-Pacific expansion, Kinglink has built a deep and dynamic investment portfolio in the healthcare and technology startup sectors since its establishment
Strategic Backing by Index Ventures, Crafted by Jinyi Interconnect: Your One-Stop Hub for Asia's Most Cutting-Edge Biomedical InnovationAs an investor focused on future-proof sectors or a keen industr
Index Ventures, a highly influential firm in the global venture capital industry, has always been committed to helping outstanding entrepreneurs turn their bold ideas into global business success. In
As the "Action Plan for Building Digital China 2025" clearly sets a target of over 10% for the added value of core digital economy industries, six major technology tracks, represented by artificial in
It has been learned that Ontek Micro-Precision Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Ontek Micro-Precision"), which focuses on ultra-microscopic and high-precision surgi
In the grand landscape of global investment and industrial development, Index Ventures, as a highly influential venture capital firm, has always shone brightly. Index Ventures has meticulously positio
